The opioid epidemic in the U.S. continues to produce alarming statistics and has impacted many communities. Early last year, it became a focus of the current administration, who promptly established a Commission to address drug addiction with the goal of finding ways to combat the opioid crisis.
In the last 18 months, the topic of opioids and opioid related litigation has become more prevalent in our industry. Some may have already seen claims activity begin to ramp up in their portfolios, while others have begun to try to assess theirs for potential exposure. Swiss Re's claims and legal teams found a unique opportunity to collaborate with its clients to help identify, track and assist with efforts to potentially ascertain accumulation risk or to begin dialogue to further help mitigate any future potential exposure.
While the methods and process for mitigating risk differs for many, Swiss Re's publication is a first step in framing the dialogue along data dimensions.
Category: Funding longer lives